Two Sigma Advisers
GUTS icon

Two Sigma Advisers’s Fractyl Health GUTS Stock Holding History

Two Sigma Advisers’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,298,700
Closed -$2.86M – 2229
2025
Q4 		$2.86M Buy
+1,298,700
New +$2.09M 0.01% 1043

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers's GUTS Position: Q1 2026 in Review

Two Sigma Advisers sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 1,298,700 shares — an estimated $2.86M sold.

Two Sigma Advisers first reported a position in GUTS in Q4 2025 and held it in 1 quarter. The position peaked at $2.86M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Two Sigma Advisers reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 1,298,700 Fractyl Health shares in Q1 2026, an estimated $2.86M.
  • Two Sigma Advisers first reported a position in Fractyl Health in Q4 2025 and held it in 1 quarter.
  • Two Sigma Advisers's Fractyl Health position peaked at $2.86M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.